Table 5.
The 17 transcripts obtained by the sequence backward selection method with the disease-free survival area
| Transcript | Classification ability% (Rank) | Disease-free survival area% (Rank) | Rank (p-value) |
|---|---|---|---|
| CCL16 | 74.36 (1) | 43.58 (2) | 5 |
| GLI3 | 71.79 (2) | 34.43 (6) | 15 |
| TUB | 71.79 (3) | 35.71 (4) | 13 |
| PRKCB1-1 | 70.51 (4) | 34.51 (5) | 3 |
| ZAP70 | 67.95 (5) | 29.53 (8) | 14 |
| ELF5 | 67.95 (6) | 26.70 (10) | 17 |
| EDN1 | 66.67 (7) | 31.09 (7) | 9 |
| SF1 | 66.67 (8) | 25.87 (11) | 8 |
| CREG1 | 66.67 (9) | 23.40 (14) | 2 |
| MAST1 | 65.38 (10) | 23.71 (13) | 12 |
| CSNK1A1 | 64.10 (11) | 24.95 (12) | 11 |
| HDAC9 | 64.10 (12) | 27.78 (9) | 10 |
| MAK | 62.82 (13) | 38.76 (3) | 4 |
| CCL15 | 61.54 (14) | 22.94 (15) | 6 |
| PRKCB1-2 | 61.54 (15) | 16.73 (17) | 1 |
| CDKN2AIP | 61.54 (16) | 46.00 (1) | 16 |
| FOXE1-1 | 60.26 (17) | 19.60 (16) | 7 |